id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
1293644,c56f3f7a-3b30-4900-8308-ff42517a69db,3T,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,TETHYS BIOSCIENCE,2012,third_quarter,MED,Regulation and reimbursement of laboratory developed tests.,"Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",10000,,0,1,2012-08-24T13:11:00.347000-04:00
1293926,b7abe00d-2ef4-4cea-9506-a8a7c3d92121,3T,"KSCW, INC.",21596,INTERNATIONAL ASSOCIATION OF MEDICAL EQUIPMENT REMARKETERS AND SERVICERS (IAMERS,2012,third_quarter,MED,"S.3187: Food and Drug Administration Safety and Innovation Act, Provisions affecting the Medical device industry
H.R.436: Health Care Cost Reduction Act of 2012  provisions related to the medical device excise tax
S.262  A bill to repeal the excise tax on medical device manufacturers.","HOUSE OF REPRESENTATIVES,SENATE",10000,,0,1,2012-09-04T15:15:57.380000-04:00
1294703,1efcf4fd-289b-4543-b255-9ed3f41b9743,Q3,MARSHALL BRACHMAN,6848,BAYLOR SCOTT AND WHITE HEALTH -- FORMERLY BAYLOR HEALTH CARE SYSTEM,2012,third_quarter,MED,support funding for medical research programs,"HOUSE OF REPRESENTATIVES,SENATE",33000,,0,0,2012-10-01T10:45:21.060000-04:00
1294892,87be6ded-0bf6-4822-ad84-6f8c67c24ba1,Q3,THE HARRIS FIRM,68376,DIRECT MESSAGE LAB,2012,third_quarter,MED,Regarding funding pertaining to software communication system for chronic disease management.,"Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2012-10-02T10:25:18.823000-04:00
1294909,4837780a-b92d-4e27-b284-1de7d35ac73b,Q3,PALMETTO GROUP,18570,INTERNATIONAL AIDS VACCINE INITIATIVE,2012,third_quarter,MED,"Federal Funding of AIDS vaccine
S.3241 Department of State, Foreign Operations, and Related Programs Appropriations Act, 2013",SENATE,22500,,0,0,2012-10-02T10:54:30.803000-04:00
1294933,61c20c67-fb6b-4e26-b84c-b988f2572b8a,Q3,"FEDERAL SOLUTIONS, LLC",311371,JACKSONVILLE STATE UNIVERSITY,2012,third_quarter,MED,"Labor/HHS/Education Appropriations Bill 2012: Provisions relating to disease research, education, and development","HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2012-10-02T11:40:43.953000-04:00
1294955,cc879ff9-72f6-4c59-9fc9-9634faa68408,Q3,"FEDERAL SOLUTIONS, LLC",311371,MISSISSIPPI STATE UNIVERSITY,2012,third_quarter,MED,Labor/HHS/Education Appropriations Bill 2012: Provisions relating to disease research,"Agriculture, Dept of (USDA),Education, Dept of,HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Oceanic & Atmospheric Administration (NOAA),SENATE",50000,,0,0,2012-10-02T11:42:48.153000-04:00
1295151,8ee1d045-b7b2-479a-a8a7-ec8038ded7c7,Q3,AMERICAN COLLEGE OF CLINICAL PHARMACY,57258,AMERICAN COLLEGE OF CLINICAL PHARMACY,2012,third_quarter,MED,Focus interactions with the Agency for Healthcare Research and Quality (AHRQ) on the issue of Quality of Medication Therapy Management Services delivered programs authorized by the Patient Protection and Affordable Care Act (PPACA PL 111-148) and  Medicare Part D plans.,"Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE",,61700,0,0,2012-10-03T11:38:48.013000-04:00
1295219,2e351b79-4bc4-4436-94ea-a16073fe238c,Q3,THOMPSON HINE LLP,38051,TEXAS BIOMEDICAL RESEARCH INSTITUTE,2012,third_quarter,MED,"Legislative and regulatory matters regarding the use of chimpanzees in biomedical research (i.e., the Great Ape Protection and Cost Savings Act and possible ""endangered species"" designation for chimpanzees by the U.S. Fish and Wildlife Service).","HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2012-10-03T15:42:36.757000-04:00
1295414,c14d7914-5a0c-40e6-b795-ea235af4edee,Q3,"RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC)",400361684,"VIJUK EQUIPMENT, INC.",2012,third_quarter,MED,all matters dealing with pharmaceutical labeling,Food & Drug Administration (FDA),25000,,0,0,2012-10-04T14:45:29.110000-04:00
1295417,72f83c71-1c13-4dc5-95b0-4914d4e85d82,Q3,GRIZZLE COMPANY,16987,UNIVERSITY OF LOUISVILLE,2012,third_quarter,MED,Request support for NIH grant application,,40000,,0,0,2012-10-04T14:46:30.187000-04:00
1295549,3f79de6a-bc6a-4cc4-83d6-6dab786f391c,Q3,"PARRY, ROMANI, DECONCINI & SYMMS",30792,"BRAIDWOOD MANAGEMENT, INC.",2012,third_quarter,MED,"Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens.  No specific legislation has been introduced yet.
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications.   No specific legislation has been introduced yet.","HOUSE OF REPRESENTATIVES,SENATE",11250,,0,0,2012-10-05T13:14:14.943000-04:00
1295559,88c9c96b-fbd1-48d7-933a-152ef81527bd,Q3,"PARRY, ROMANI, DECONCINI & SYMMS",30792,DIAMONDBACK DRUGS,2012,third_quarter,MED,"Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens.   No specific legislation has been introduced yet.
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications.  No specific legislation has been introduced yet.","HOUSE OF REPRESENTATIVES,SENATE",6000,,0,0,2012-10-05T13:35:19.340000-04:00
1295580,508810e1-0f7b-494c-afef-7241dc4e60f0,Q3,"PARRY, ROMANI, DECONCINI & SYMMS",30792,"VETERINARY PHARMACIES OF AMERICA, INC.",2012,third_quarter,MED,"Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens.  No specific legislation introduced yet.
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications.  No specific legislation introduced yet.","HOUSE OF REPRESENTATIVES,SENATE",11250,,0,0,2012-10-05T14:39:33.297000-04:00
1295591,2f46c21f-df05-402f-b105-0ba48de4a478,Q3,"PARRY, ROMANI, DECONCINI & SYMMS",30792,"WEDGEWOOD VILLAGE PHARMACY, INC.",2012,third_quarter,MED,"Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens.  No specific legislation introduced yet.
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications.  No specific legislation introduced yet.","HOUSE OF REPRESENTATIVES,SENATE",11250,,0,0,2012-10-05T14:45:38.743000-04:00
1295602,1488395d-1238-473b-9275-c49f2224b83a,Q3,"PARRY, ROMANI, DECONCINI & SYMMS",30792,"WOMEN'S INTERNATIONAL PHARMACY, INC.",2012,third_quarter,MED,"Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens.  No specific legislation introduced yet.
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications.  No specific legislation introduced yet.","HOUSE OF REPRESENTATIVES,SENATE",11250,,0,0,2012-10-05T14:53:44.530000-04:00
1295676,3c0a29e9-2db4-4dd5-9d40-f8b3f0324c53,Q3,"CAPITOL CONSULTING GROUP, LLC",400366700,TERUMO BCT (FORMERLY CARIDIANBCT BIOTECHNOLOGIES LLC),2012,third_quarter,MED,Blood pathogen reduction technology development,"HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2012-10-07T19:47:29.497000-04:00
1295732,8598c359-ca70-4cac-9da3-4c906139fc9a,Q3,UNIVERSITY OF IOWA,49191,UNIVERSITY OF IOWA,2012,third_quarter,MED,"FY 2011 Appropriations                                                      Residency Caps
FY 2012 Appropriations                                                      Minority Improvement
Medical Affordability Act                                                   False Claims Correction Act
Research Misconduct Clinical Trials                                 NIOSH Education and Research Centers for Occupational Health and Safety Pathways for Biosimilars Act
Prevention Research Centers
Resident Physician Shortage
Health Care Reform
FY 2013 Appropriations","Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT)",,88684,0,0,2012-10-08T10:26:43.090000-04:00
1295881,64ab44eb-ee70-47cd-bb1d-7516ac25e047,Q3,"CAPITOL CONSULTING GROUP, LLC",400366700,HUMACYTE INCORPORATED,2012,third_quarter,MED,Research and development of products for vascular disease and for therapeutic filling and soft tissue repair,"HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2012-10-08T16:11:10.420000-04:00
1296164,33a9e998-7bb3-4560-a758-056964a20ebb,Q3,"PARRY, ROMANI, DECONCINI & SYMMS",30792,AIDS HEALTHCARE FOUNDATION,2012,third_quarter,MED,"Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2012 - Support funding for medical treatment for HIV positive patients.  Support appropriate funding for the ADAP program.  Continue appropriate funding for Chronic Care Special Needs clinics under Medicare.","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2012-10-09T16:24:36.550000-04:00
1296325,488bd6ed-7a7e-4cd5-9bd7-ef1f1b31493f,Q3,DENNY MILLER ASSOCIATES,25328,SABEY CORPORATION,2012,third_quarter,MED,Federal grant funding for medical education and research facilities.,"Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2012-10-10T10:50:54.020000-04:00
1296377,22e2c0bc-17cf-4468-a5d1-49d5d62a153c,Q3,AMERICAN ASSOCIATION FOR CANCER RESEARCH,400601833,AMERICAN ASSOCIATION FOR CANCER RESEARCH,2012,third_quarter,MED,"H.R. 733/S. 362, the Pancreatic Cancer Research and Education Act and its substitute, the Recalcitrant Cancer Act of 2012","HOUSE OF REPRESENTATIVES,SENATE",,25000,0,0,2012-10-10T11:21:09.450000-04:00
1296597,1a806cf8-25ed-42be-84bf-0769318f1885,Q3,ASSN OF MEDICAL DEVICE REPROCESSORS,291732,ASSN OF MEDICAL DEVICE REPROCESSORS,2012,third_quarter,MED,"Educated Congressional staff, members of Congress, and other agency officials on the FDA-regulated, third-party reprocessing industry and ongoing efforts to implement similar regulations internationally. Initiated discussions on MDUFA reauthorization. Contacted VA about hospital regulations for reprocessed single-use medical devices.","Commerce, Dept of (DOC),Environmental Protection Agency (EPA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE,U.S. International Trade Commission (ITC),Veterans Affairs, Dept of (VA)",,20000,0,0,2012-10-10T14:50:57.877000-04:00
1297376,24b2382d-07f9-4deb-918d-675584f7d756,Q3,PETERSON GROUP (FL),400920675,"CLEVELAND BIOLABS, INC.",2012,third_quarter,MED,"Homeland security, civil defense, and health issues involving nuclear radiation exposure. Creating Congressional awareness of nuclear radiation threats and need to support speedy development of countermeasures. No specific legislation at this time.","HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2012-10-11T20:09:24.300000-04:00
1297417,8d4d624e-a864-4084-931e-5d979116566a,Q3,LNE GROUP,308811,OHIOGUIDESTONE (FORMALLY KNOWN AS GUIDESTONE),2012,third_quarter,MED,"Lobbied for issues within the medical field including reseach, and clinical labs","HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2012-10-12T09:32:49.483000-04:00
1297466,0f546b81-9adb-46cc-a16d-0666d835e171,Q3,LNE GROUP,308811,INTRINSIQ MATERIALS,2012,third_quarter,MED,Lobbied for issues regarding the medical research,"HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2012-10-12T10:17:13.837000-04:00
1297554,0b2ed80c-4698-4cc0-80c4-93fb534529ea,Q3,WAKE FOREST UNIVERSITY HEALTH SCIENCES,6781,WAKE FOREST UNIVERSITY HEALTH SCIENCES,2012,third_quarter,MED,"NIH Budget including Title VII & VIII programs
VA-Outpatient Clinic in N.C.(RFP-land acquisition)","Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA)",,145000,0,0,2012-10-12T11:06:43.843000-04:00
1297765,f05ebfd6-ff0c-42ba-b941-2c6c6e1bb44d,Q3,LNE GROUP,308811,ZIMMER,2012,third_quarter,MED,Lobbied for medical device issues.,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2012-10-12T13:24:46.227000-04:00
1297791,4cb1b891-c525-4c3e-b3b7-c2e28428dc99,Q3,INTERNATIONAL MYELOMA FOUNDATION,400595820,INTERNATIONAL MYELOMA FOUNDATION,2012,third_quarter,MED,"HR 2746, Cancer Drug Coverage Parity Act","HOUSE OF REPRESENTATIVES,SENATE",,50500,0,0,2012-10-12T13:53:02.680000-04:00
1297846,d199be5f-a378-4df3-9d91-23cb6915da46,Q3,THOMPSON HINE LLP,38051,NEW IBERIA RESEARCH CENTER -- UNIVERSITY OF LOUISIANA AT LAFAYETTE,2012,third_quarter,MED,"Legislative and regulatory matters regarding the use of chimpanzees in biomedical research (i.e., the Great Ape Protection and Cost Savings Act and possible ""endangered species"" designation for chimpanzees by the U.S. Fish and Wildlife Service).","HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2012-10-12T14:32:25.820000-04:00
1297946,deb99f49-e730-4091-94b7-b639e29f754e,Q3,LATHAM & WATKINS LLP,22201,BOSTON SCIENTIFIC CORPORATION,2012,third_quarter,MED,Congressional oversight of the Food and Drug Administration.,"Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2012-10-12T15:52:15.290000-04:00
1298119,6ce17f29-fccd-4c9f-908c-b4260ee24ed3,Q3,BEN BARNES GROUP LP,5415,FAIR LABORATORY PRACTICES ASSOCIATION,2012,third_quarter,MED,Bring attention to prevention of unfair billing practices by laboratories for Medicare services,SENATE,30000,,0,0,2012-10-13T12:34:30.763000-04:00
1298125,ec816d36-104d-494d-b600-dd44ab09251b,Q3,BEN BARNES GROUP LP,5415,OKLAHOMA RESEARCH MEDICAL FOUNDATION,2012,third_quarter,MED,IDEA funding for smaller states,SENATE,20100,,0,0,2012-10-13T13:19:35.650000-04:00
1298137,d339769b-0562-4f4c-b216-4ba71d4781be,Q3,BEN BARNES GROUP LP,5415,"ROYALTY PHARMA - / RP MANAGEMENT, LLC",2012,third_quarter,MED,Correct publicly traded partnership rules on passive income,"HOUSE OF REPRESENTATIVES,SENATE",150000,,0,0,2012-10-13T14:23:42.333000-04:00
1299015,d15869e2-bfcd-4dfa-8a89-eab28aa0fa78,Q3,DENNY MILLER ASSOCIATES,25328,CELL THERAPEUTICS,2012,third_quarter,MED,"S. 3187, Food and Drug Administration Safety and Innovation Act of 2012, provisions relating to the approval of new drugs.","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2012-10-15T13:55:42.557000-04:00
1299616,8397a812-5013-4f2d-953c-a0caf9229729,Q3,WEBMD HEALTH CORP.,55473,WEBMD HEALTH CORP,2012,third_quarter,MED,"Explore partnership opportunities with the government to disseminate healthcare and research information to physicians and consumers.  Federal health care reform efforts.  Privacy, security and confidentiality issues; Direct to consumer advertising; Wellness programs and incentives for creation of such programs; Pharma issues related to both advertising and the deduction of expenses associated with advertising; Personal health records.",SENATE,,30000,0,0,2012-10-15T17:28:52.837000-04:00
1300071,c63ebfbf-1a54-471f-9eb0-b3055cbe807b,Q3,THE NATIONAL ALLIANCE FOR EYE AND VISION RESEARCH,314055,THE NATIONAL ALLIANCE FOR EYE AND VISION RESEARCH,2012,third_quarter,MED,Support for the National Eye Institute at the National Institues of Health; Support for medical research programs at the Department of Defense,"HOUSE OF REPRESENTATIVES,SENATE",,61500,0,0,2012-10-16T09:43:16.490000-04:00
1300198,74d438d8-5088-4e56-b8a6-51b42ac26840,Q3,PRINCETON UNIVERSITY,308695,PRINCETON UNIVERSITY,2012,third_quarter,MED,S. 810; H.R. 1513: Great Ape Protection and Cost Savings Act of 2011,"Energy, Dept of,HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),Office of Science & Technology Policy (OSTP),SENATE,White House Office",,30000,0,0,2012-10-16T10:51:06.330000-04:00
1300241,bbcd83a6-23ce-45db-89b9-8f3a14d75ee4,Q3,INFECTIOUS DISEASES SOCIETY OF AMERICA,54836,INFECTIOUS DISEASES SOCIETY OF AMERICA,2012,third_quarter,MED,Medical liability; antimicrobial resistance research; infectious diseases product research and development; regulatory science; unnecessary regulatory burdens placed on medical research; laboratory developed tests; comparative effectiveness research; support for evidence-based decision making; point-of-care diagnostic tests; and organ transplant policy to allow HIV+ to HIV+ organ transplants,"Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,U.S. Agency for International Development (USAID)",,87400,0,0,2012-10-16T11:12:40.430000-04:00
1300449,5f97b9a4-b547-45b5-9aa2-698214e287d6,Q3,WASHINGTON UNIVERSITY IN ST. LOUIS,40031264,WASHINGTON UNIVERSITY IN ST LOUIS,2012,third_quarter,MED,"General advocacy for NIH research, genomics research, and improved conflict of interest policies.  Advocacy in support of clear, productive federal stem cell research guidelines.","HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),Office of Science & Technology Policy (OSTP),SENATE",,30000,0,0,2012-10-16T12:30:42.807000-04:00
1300531,0b0fe808-c8ff-47a5-947f-f783fc250a53,Q3,"MEHLMAN CONSULTING, INC.",284950,NATIONAL VENTURE CAPITAL ASSOCIATION,2012,third_quarter,MED,"FDA reform:  Changes to PDUFA (Prescription Drug User Fee Act) and MDUFA (Medical Device User Fee Act) programs.
H.R. 4132, Faster Access to Specialized Treatments (FAST) Act; S. 2113, Transforming the Regulatory Environment to Accelerate Access to Treatments (TREAT) Act; H.R. 2182, Generating Antibiotic Incentives Now (GAIN) Act of 2011; S. 2236, Advancing Breakthrough Therapies for Patients Act of 2012  (See continuation page) H.R. 5651, Food and Drug Administration Reform Act of 2012.
S. 3187, Food and Drug Administration Safety and Innovation Act.  (Became Public Law 112-144)","Executive Office of the President (EOP),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE,Treasury, Dept of",60000,,0,0,2012-10-16T13:02:38.363000-04:00
1300835,475070b6-8fdb-4556-8b7d-7a9949282b77,Q3,"DALRYMPLE & ASSOCIATES, LLC",5073,EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION),2012,third_quarter,MED,"Biodefense and naturally-occurring vaccine and related biological therapeutic products and civilian oncology therapeutic products research and development funding, legislation, appropriations and oversight.","Army, Dept of (Other),Ballistic Missile Defense Organization,Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Defense Threat Reduction Agency (DTRA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office",63000,,0,0,2012-10-16T14:26:43.990000-04:00
1300848,81002137-4bdd-494e-857c-db18ccd21393,Q3,"DALRYMPLE & ASSOCIATES, LLC",5073,SANOFI PASTEUR,2012,third_quarter,MED,"Vaccine research and development legislation, funding, appropriations and oversight.","Army, Dept of (Other),Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Defense Threat Reduction Agency (DTRA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,State, Dept of (DOS),U.S. Agency for International Development (USAID),Veterans Affairs, Dept of (VA),White House Office",46000,,0,0,2012-10-16T14:31:52.140000-04:00
1300868,da3cea94-bfd6-4544-a532-029667ab201c,Q3,"DALRYMPLE & ASSOCIATES, LLC",5073,DISCOVERY LABORATORIES,2012,third_quarter,MED,"Small peptide synthetic lung surfactant and medical device delivery medical countermeasures against CBRN threats research and development grant and contract funding opportunities, legislation, appropriations and oversight.","Army, Dept of (Other),Ballistic Missile Defense Organization,Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Defense Threat Reduction Agency (DTRA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office",16000,,0,0,2012-10-16T14:35:58.683000-04:00
1301072,3285bdb5-e4d7-4db4-8c44-b0ebed270712,3T,POLICY DIRECTIONS INC.,31747,BAYLOR COLLEGE OF MEDICINE,2012,third_quarter,MED,"S. 606  and HR 3059- Creating Hope Act of 2011 - issues related to neglected tropical disease research and treatment.
HR 528 - Neglected Infections of Impoverished Americans Act of 2011.","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,1,2012-10-16T15:16:15.907000-04:00
1301108,0e0e0ad0-391b-4ecd-936d-f1a663bced01,Q3,POLICY DIRECTIONS INC.,31747,COVANCE INC,2012,third_quarter,MED,"No Bills.
Issues related to FDA regulatory requirements for product testing.","Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2012-10-16T15:19:24.733000-04:00
1301174,357410b0-0f85-4e98-b455-8fece96f843e,Q3,"MEHLMAN CONSULTING, INC.",284950,AMERICAN CLINICAL LABORATORY ASSOCIATION,2012,third_quarter,MED,"Health reform law implementation issues including application of medical device tax to clinical laboratory tests and laboratory fee schedule.      In-office ancillary services exception to Stark Law.    
H.R. 3207, The Modernizing Laboratory Test Standards for Patients Act.","Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE",60000,,0,0,2012-10-16T15:29:54.643000-04:00
1301329,6d6ddc9f-8b21-4f8d-a2a7-796229fb4291,Q3,PHILIP W. JOHNSTON ASSOCIATES,400278335,JUSTICE RESOURCE INSTITUTE,2012,third_quarter,MED,Issues related to National Child Traumatic Stress Network.,"HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2012-10-16T16:30:14.110000-04:00
1301431,612fe9b3-409e-48cf-80f1-f00ffe84cf14,Q3,AMERICAN ACADEMY OF FAMILY PHYSICIANS,1342,AMERICAN ACADEMY OF FAMILY PHYSICIANS,2012,third_quarter,MED,"H.R.5888, Physician Reentry Demonstration Program, Bill attempts to address the shortage of primary care physicians.","Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),Office of Management & Budget (OMB),SENATE,White House Office",,449038,0,0,2012-10-16T16:53:55.267000-04:00
1301481,79a0704b-9e3d-4f6f-8094-8d316a32836a,Q3,AMERICAN ASSOCIATION FOR HOMECARE,55792,AMERICAN ASSOCIATION FOR HOMECARE,2012,third_quarter,MED,"Issues pertaining to durable medical equipment including: bidding, power wheelchairs, oxygen, diabeti supplies, negative pressure wound therapy, Medicare audits, and fraud abuse; H.R. 1041 - Fairness in Medicare Bidding Act, all provisions; H.R. 3399/S. 1251 - Medicare and Medicaid FAST Act, all provisions; H.R. 452 -  Medicare Decisions Accountability Act of 2011, all provisions; S.668 - Health Care Bureaucrats Elimination Act, all provisions; H.R. 3630 - Middle Class Tax Relief and Job Creation Act of 2012, all provisions; H.Con.Res. 112 - House Budget Resolution for Fiscal Year 2013, all provisions; S.3187 - Food and Drug Administration Safety and Innovation Act, all provisions; H.R. 4378 - Ensuring Access to Quality Complex Rehabilitation Technology Act of 2012, all provisions; H.R. 5652 - Sequester Replacement Reconciliation Act of 2012, issues pertaining to Medicare; CMS prior authorization demonstration for power mobility devices. H.R. 6490 - Medicare DMEPOS Market Pricing Program Act of 2012, all provisions.","Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Natl Economic Council (NEC),Office of Management & Budget (OMB),SENATE,Treasury, Dept of,White House Office",,170000,0,0,2012-10-16T17:36:25.827000-04:00
1301630,7673e8bf-d370-4e86-8491-cebfbd86d126,Q3,VAN SCOYOC ASSOCIATES,39837,"ELECTROCHEMICAL OXYGEN CONCEPTS, INC. DBA EO2 CONCEPTS",2012,third_quarter,MED,No lobbying activity.,"Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2012-10-17T06:39:52.180000-04:00
1301635,5b98ba51-e4ce-4bc9-98f9-e1b5ca0fe4cc,Q3,VAN SCOYOC ASSOCIATES,39837,MEDICINES FOR MALARIA VENTURE,2012,third_quarter,MED,USAID and Malaria research and development issues and initiatives,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2012-10-17T06:43:54.130000-04:00
1301822,c0db0334-9cb5-424a-b20e-6c9b2ef8fa40,Q3,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,TUBEROUS SCLEROSIS ALLIANCE,2012,third_quarter,MED,"S.3295, Labor-HHS-Education Appropriations Bill, FY 2013, Tuberous Sclerosis
HR 5856, Defense Appropriations, FY 2013
Defense health programs, Tuberous Sclerosis Complex Research Program","HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",20000,,0,0,2012-10-17T09:36:15.270000-04:00
1301882,d26fdf7b-8fdd-4506-a52e-612a81dee493,Q3,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,"SAGE PUBLICATIONS, INC.",2012,third_quarter,MED,"HR4004, S.2096, Federal Research Public Access Act; National Institutes of Health Open Access policy
No Bill#, America COMPETES Act, implementation of public access policy at federal science agencies
S.3295, Labor-HHS-Education Appropriations Bill, FY 2013, NIH Open Access Policy, Department of Education Title II Funding
HR3699, Research Works Act No Bill#, Reauthorization of Elementary and Secondary Education Act, Title II Funding","HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2012-10-17T09:51:42.363000-04:00
1301895,20b3a907-3f78-4d00-a0cb-432fb2a97059,Q3,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,APLASTIC ANEMIA & MDS INTERNATIONAL FOUNDATION,2012,third_quarter,MED,"S.3295, Labor-HHS-Education Appropriations Bill, FY 2013, biomedical research
HR 5856, Defense Appropriations Bill, FY 2013, defense health programs, research for bone marrow failure disease
HR 640, Bone Marrow Failure Disease Research and Treatment Act","Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",20000,,0,0,2012-10-17T09:56:48.590000-04:00
1301937,4e39664a-ec22-4a89-9990-fc96d783377e,Q3,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,DIADEXUS INC,2012,third_quarter,MED,"H.R. 436 Health Care Cost Reduction Act
Public Law No: 112-144 Food and Drug Administration Safety and Innovation Act
Reimbursement of laboratory tests","HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2012-10-17T10:06:09.420000-04:00
1301955,03b7d63d-e29e-4296-8670-388d1adab116,Q3,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,CRESCENDO BIOSCIENCE INC.,2012,third_quarter,MED,"Biomedical research, treatment of rheumatoid arthritis, public-private partnerships, oversight and reimbursement of laboratory testing. HR 436, Health Care Cost Reduction Act","HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",,,0,0,2012-10-17T10:09:15.557000-04:00
1301984,3d04c802-5466-4595-8121-ea7d8921d561,Q3,NORTHWESTERN UNIV,299992,NORTHWESTERN UNIV,2012,third_quarter,MED,"H.R. 2146, The Digital Accountability and Transparency Act, entire bill
S. 1627, Resident Physician Shortage Act of 2011, entire bill
H.R. 3433, The Grant Reform and Transparency Act of 2011, The Grant Act, entire bill
H.R. 3699, The Research Works Act, entire bill S. 2096/H.R. 4004, Federal Research Public Access Act, entire bill","HOUSE OF REPRESENTATIVES,SENATE",,86000,0,0,2012-10-17T10:15:25.610000-04:00
1301990,08342c17-6f3b-4af9-9d88-983bb6170ccb,Q3,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,ASSOCIATION FOR MOLECULAR PATHOLOGY,2012,third_quarter,MED,"Issues impacting the legislative and regulatory oversight of laboratory developed tests, reimbursement of diagnostic tests, DNA patents, workforce issues, standards development for diagnostics. No Bill#: Genomic Research and Accessibility Act; No Bill#: BETTER Patient Care; HR 3207: Modernizing Laboratory Test Standards for Patients Act; HR 3497 MODDERN Cures Act","Agency for Healthcare Research & Quality (AHRQ),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Patent & Trademark Office (PTO),SENATE",30000,,0,0,2012-10-17T10:16:27.250000-04:00
1302021,5fa0d8ae-c11b-4f21-9e06-7929ba2d1ab3,Q3,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,ONYX PHARMACEUTICALS,2012,third_quarter,MED,"Innovation in biotechnology; patient access to treatments; FDA accelerated approval process; orphan drugs for rare diseases, health disparities, drug shortages.  Public Law No: 112-144 Food and Drug Administration Safety and Innovation Act","Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",30000,,0,0,2012-10-17T10:23:40.740000-04:00
1302023,7155ac94-9880-4141-9fee-6b88b45f99f5,Q3,SRI INTERNATIONAL,90990,SRI INTERNATIONAL,2012,third_quarter,MED,"Pandemic and All-Hazards Preparedness Reauthorization Act of 2011 (HR 2405, S 1855)
FY 13 House and Senate Labor/HHS/Education Appropriations (S 3295)","HOUSE OF REPRESENTATIVES,SENATE",,90000,0,0,2012-10-17T10:23:41.803000-04:00
1302031,83345244-bba1-41d2-a0b0-7db6233da765,Q3,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,INTERNATIONAL MYELOMA FOUNDATION,2012,third_quarter,MED,HR 2746 Cancer Drug Coverage Parity Act,"HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2012-10-17T10:26:45.317000-04:00
1302191,1c710388-bb1b-498a-a6d6-10902e79f5c6,3T,"THE PETRIZZO GROUP, INC.",305932,"SAGE THERAPEUTICS, INC.",2012,third_quarter,MED,"Advocated for federal funding to support development of neuroactive steroids research yielding therapeutics with a core focus on Traumatic Brain Injury (TBI), Post-Traumatic Stress Disorder (PTSD), and Pain.","Defense, Dept of (DOD)",10000,,0,1,2012-10-17T10:57:34.887000-04:00
1302194,0e83a118-fdb8-4e94-ab65-81ceadc3fb9e,Q3,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,AMERICAN SOCIETY OF HEMATOLOGY,2012,third_quarter,MED,Research in hematology.,"Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",30000,,0,0,2012-10-17T10:58:36.760000-04:00
1302228,8f18dd39-e2e9-4a6c-a68b-4c823be64243,Q3,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,ASSOCIATION OF AMERICA'S BLOOD BANKS,2012,third_quarter,MED,"Blood safety and management issues.  HHS Advisory Committee on Blood Safety and Availability. 
Research related to Biovigilance.","Centers For Disease Control & Prevention (CDC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2012-10-17T11:02:46.897000-04:00
1302273,69ab41ef-f4e7-4f18-8a91-5d7ab1ce7478,Q3,"DESIMONE CONSULTING, LLC",400931695,PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA),2012,third_quarter,MED,"Issues related to access to medicines and other medical therapies, the development of new medical therapies and regulatory matters regarding the bio-pharmaceutical industry.","HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2012-10-17T11:09:07.217000-04:00
1302384,620202c3-0809-4fa2-a6e8-df1432ae2eb1,Q3,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,NATIONAL HEMOPHILIA FOUNDATION,2012,third_quarter,MED,"Hemophilia research, prevention, surveillance and service programs and issues. HR1919 Bleeding Disorders Screening Awareness and Further Education Act of 2011","Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",50000,,0,0,2012-10-17T11:22:02.093000-04:00
1302401,b1a800cb-ab48-498b-b1c5-0188d6d5a1f3,Q3,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,NATIONAL ASSOCIATION OF EPILEPSY CENTERS,2012,third_quarter,MED,Research and public health programs in epilepsy.,"Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",10000,,0,0,2012-10-17T11:24:10.340000-04:00
1302801,f1a09994-8a4d-4b76-a566-2225872503b2,Q3,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,STATE UNIVERSITY SYSTEM OF FLORIDA,2012,third_quarter,MED,Appropriations and Authorization legislation for FY 2013 in health care,"Agriculture, Dept of (USDA),Defense, Dept of (DOD),Education, Dept of,Energy, Dept of,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Interior, Dept of (DOI),SENATE",70000,,0,0,2012-10-17T12:48:57.257000-04:00
1302948,b7104881-d2fd-4d25-8074-037f1bac30d5,Q3,"THE PETRIZZO GROUP, INC.",305932,ORLANDO HEALTH,2012,third_quarter,MED,"-Concerns with issues surrounding the Medicaid expansion of the ACA and Disproportionate Share Hospital (DSH) cuts.
-Concerns with issues regarding Medicaid being used as an offset for tax cuts and sequestration.","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2012-10-17T13:37:58.713000-04:00
1303177,27ff35c2-c3c5-45f7-8606-358f49886aef,Q3,FIRST STRATEGIC,91091,PHOENIX CHILDREN'S HOSPITAL,2012,third_quarter,MED,"Policies and legislation that may impact the hospital and its operations such as SCHIP/CHIPRA, 340b, children's graduate medical education (CHGME), disproportionate share hospital (DSH) funding, Medicaid and healthcare reform related provisions. Creation of the saftey net care pool through CMS.","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2012-10-17T14:14:24.437000-04:00
1303241,a2065b01-9d6b-4380-9354-5edccc035ad3,Q3,FIRST STRATEGIC,91091,TRANSLATIONAL GENOMICS RESEARCH INSTITUTE,2012,third_quarter,MED,The Creating Hope Act - issues regarding drug development for pediatric rare diseases.,"HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2012-10-17T14:22:52.110000-04:00
1303327,be0ed283-6b72-4859-8e47-5426ad8e49f9,Q3,PHOENIX CHILDREN'S HOSPITAL,400381743,PHOENIX CHILDREN'S HOSPITAL,2012,third_quarter,MED,"Policies and legislation that may impact the hospital and its operations such as SCHIP/CHIPRA, 340b, children's graduate medical education (CHGME), disproportionate share hospital (DSH) funding, Medicaid and healthcare reform related provisions. Creation of the saftey net care pool through CMS.","HOUSE OF REPRESENTATIVES,SENATE",,30000,0,0,2012-10-17T14:32:33.443000-04:00
1303520,648ff068-83ba-4b6a-95b2-d442c3330d82,Q3,LIFE TECHNOLOGIES CORPORATION,400391833,LIFE TECHNOLOGIES CORPORATION,2012,third_quarter,MED,"Draft guidance regarding Commercially Distributed In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only: Frequently Asked Questions; Provisions regarding FDA regulation of certain diagnostics.
Unique Device Identifier proposed rule; Provisions regarding date format.","HOUSE OF REPRESENTATIVES,SENATE",,170000,0,0,2012-10-17T14:47:41.083000-04:00
1303537,c5375972-3891-4cde-9b67-dd18e6deae6c,Q3,PHYSICIANS COMMITTEE FOR RESPONSIBLE MEDICINE,400382759,PHYSICIANS COMMITTEE FOR RESPONSIBLE MEDICINE,2012,third_quarter,MED,The Preservation of Antibiotics for Medical Treatment Act-HR 965/S.1211,"HOUSE OF REPRESENTATIVES,SENATE",,32948,0,0,2012-10-17T14:48:46.177000-04:00
1303666,85f6be37-7a07-42d1-88b6-2f44167151d2,Q3,"THE PETRIZZO GROUP, INC.",305932,FRED HUTCHINSON CANCER RESEARCH CENTER,2012,third_quarter,MED,"-Advocated for funding for the National Institutes of Health and National Cancer Institute for FY 2013 funding.
-Advocated for funding by USAID for the Uganda Program on Cancer & Infectious Diseases.","HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2012-10-17T15:07:38.983000-04:00
1303686,20018c8a-682a-4c35-b63b-97233b083a0e,Q3,NATIONAL RIGHT TO LIFE COMMITTEE,28481,NATIONAL RIGHT LIFE COMMITTEE,2012,third_quarter,MED,"Reviewed H.R. 2104 (""Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act,"" ""CARE Act""); suggested possible amendments.","HOUSE OF REPRESENTATIVES,SENATE",,99173,0,0,2012-10-17T15:10:44.757000-04:00
1303838,46d0d352-7b6e-4b54-a1f7-a0466f89f688,Q3,"WHITMER & WORRALL, LLC",292892,NEURO KINETICS,2012,third_quarter,MED,Issues related to Traumatic Brain Injury (TBI).,"Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA)",10000,,0,0,2012-10-17T15:27:38.347000-04:00
1303961,cd7c9958-4460-4751-8db0-3f3d518db4de,Q3,PRIME POLICY GROUP,400532589,"VERAX BIOMEDICAL, INC.",2012,third_quarter,MED,Blood Safety,"Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2012-10-17T15:42:38.080000-04:00
1304101,e390284b-18fa-46d6-bf50-8c4ab46cf514,Q3,"PARRY, ROMANI, DECONCINI & SYMMS",30792,SANOFI US SERVICES INC (FORMERLY KNOWN AS SANOFI-AVENTIS U S INC ),2012,third_quarter,MED,"General discussions regarding the rauthorization of the Prescription Drug User Fee Act (PDUFA), S. 3187 and H.R. 5651; and education and awareness of vaccine production and infrastructure needs.","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2012-10-17T16:08:49.567000-04:00
1304207,0c02a6a1-a86e-4490-819e-c72d3aae0dff,Q3,MCDERMOTT WILL & SCHULTE LLP,24338,GENOMIC HEALTH INC,2012,third_quarter,MED,FDA regulation of laboratory-developed tests.,"Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",70000,,0,0,2012-10-17T16:27:35.247000-04:00
1304249,4c8f9a23-b186-4ed3-91d0-4a98569eb7e0,Q3,AMERICAN ASSOCIATION OF COLLEGES OF NURSING,66911,AMERICAN ASSOCIATION OF COLLEGES OF NURSING,2012,third_quarter,MED,"Lobbied Members of Congress to protect funding for research in the FY 2013 LHHS Appropriations through the National Institutes of Health, National Institute of Nursing Research, Centers for Disease Control and Prevention, and the Agency for Healthcare Research and Quality.","Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",,20000,0,0,2012-10-17T16:42:55.370000-04:00
1304351,d94d5856-1664-4eec-b255-716a2f91eb60,Q3,UNIVERSITY OF PITTSBURGH,53356,UNIVERSITY OF PITTSBURGH,2012,third_quarter,MED,Increased funding for Autism research and academic Autism research centers through NIH,"HOUSE OF REPRESENTATIVES,SENATE",,70000,0,0,2012-10-17T17:06:27.093000-04:00
1304384,83a4a24a-e806-48b5-a0e4-7fe41c333523,Q3,FAEGRE DRINKER BIDDLE & REATH LLP,12631,SPINA BIFIDA ASSOCIATION,2012,third_quarter,MED,Spina Bifida Research and Awareness and Access to Care; Folic Acid Fortification.,"Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE",20000,,0,0,2012-10-17T17:18:41.297000-04:00
1304418,9087888f-48fa-41e4-9c09-c1d743914b28,Q3,BRACEWELL LLP,6837,AIR LIQUIDE USA LLC,2012,third_quarter,MED,Worked related to medical gases,"Energy, Dept of,Environmental Protection Agency (EPA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),SENATE,Treasury, Dept of",60000,,0,0,2012-10-17T17:26:01.117000-04:00
1304435,5f5f6678-64cc-4736-bb4d-a31f648402e0,Q3,FAEGRE DRINKER BIDDLE & REATH LLP,12631,"CHILDREN'S CARDIOMYOPATHY FOUNDATION, INC.",2012,third_quarter,MED,"H.R. 3625/S.2124 - The Cardiomyopathy Health, Education, Awareness, Risk Assessment, and Training in the Schools Act;  Food and Drug Administration (FDA) Pediatric Device Research and Regulation; Cardiomyopathy Research Issues.","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2012-10-17T17:31:09.080000-04:00
1304475,576e481d-5ee2-4058-9bb0-005d73d56ef3,Q3,FAEGRE DRINKER BIDDLE & REATH LLP,12631,OVARIAN CANCER NATIONAL ALLIANCE,2012,third_quarter,MED,Ovarian Cancer Research and Awareness; Implementation of Johanna's Law.,"Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB)",10000,,0,0,2012-10-17T17:53:26.637000-04:00
1304517,f4fa1621-371b-4b8e-a6ea-389541b0d48a,Q3,FAEGRE DRINKER BIDDLE & REATH LLP,12631,PREECLAMPSIA FOUNDATION,2012,third_quarter,MED,Preeclampsia Research Issues; National Health Calendar,"Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",,,0,0,2012-10-17T18:10:44.620000-04:00
1304559,bf74b8b5-5ed3-4965-aaff-a0ec9365f331,Q3,FAEGRE DRINKER BIDDLE & REATH LLP,12631,PREVENT BLINDNESS,2012,third_quarter,MED,Eye Disease and Vision Health; Treatment and Prevention of Blindness and Vision Loss.,"HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE",10000,,0,0,2012-10-17T18:23:59.887000-04:00
1304574,6a748b5f-c563-46c2-bbf7-04845021b4f4,Q3,FAEGRE DRINKER BIDDLE & REATH LLP,12631,NATIONAL PSORIASIS FOUNDATION,2012,third_quarter,MED,"H.R. 2033/S.1107 - Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2011; Psoriasis Data Collection.","Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE",50000,,0,0,2012-10-17T18:35:04.997000-04:00
1304721,8bea93af-5779-41ea-8fbb-9dcd87862fac,Q3,THORN RUN PARTNERS,400534596,NOVARTIS CORPORATION,2012,third_quarter,MED,Issues related to biologics.,"HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2012-10-17T23:52:26.403000-04:00
1304817,59a9684b-1ed5-4ca7-b537-adf49b8544ef,Q3,VAN SCOYOC ASSOCIATES,39837,COALITION OF EPSCOR STATES,2012,third_quarter,MED,"S.3295, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2013, Biomedical related research & development initiatives; research infrastructure; IDeA program; and clinical research.","Agriculture, Dept of (USDA),HOUSE OF REPRESENTATIVES,Natl Aeronautics & Space Administration (NASA),Natl Institutes of Health (NIH),SENATE",110000,,0,0,2012-10-18T06:41:30.517000-04:00
1304828,0bd86cef-162f-481a-971e-92c8338a606d,Q3,VAN SCOYOC ASSOCIATES,39837,UNIVERSITY OF ALABAMA SYSTEM,2012,third_quarter,MED,"Funding for National Institutes of Health, and various institutes and bureaus thereof.  
Funding for Health Resources Services Administration.
Funding for Department of Defense medical research programs","HOUSE OF REPRESENTATIVES,SENATE",90000,,0,0,2012-10-18T06:42:32.030000-04:00
1304878,d60dc267-46b4-402a-bce8-e7c4c887db02,Q3,"MEHLMAN CONSULTING, INC.",284950,MAYO CLINIC,2012,third_quarter,MED,"NIH appropriations
Clinical laboratory reimbursement","Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2012-10-18T08:42:59.893000-04:00
1304998,6cd89a61-ebf3-4d3d-bef6-5abb1e6fd896,Q3,FAEGRE DRINKER BIDDLE & REATH LLP,12631,SPINA BIFIDA ASSOCIATION,2012,third_quarter,MED,Spina Bifida Research and Awareness and Access to Care; Folic Acid Fortification.,"Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE",20000,,0,0,2012-10-18T09:28:55.383000-04:00
1305017,331b8015-9524-48a1-88a7-6b5a495c4290,3A,FAEGRE DRINKER BIDDLE & REATH LLP,12631,SPINA BIFIDA ASSOCIATION,2012,third_quarter,MED,Spina Bifida Research and Awareness and Access to Care; Folic Acid Fortification.,"Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE",20000,,0,0,2012-10-18T09:36:04.500000-04:00
1305200,fe870b13-fd20-4e2c-a1b3-9f665619a113,Q3,"AUX INITIATIVES, LLC",400384779,NOVARTIS VACCINES,2012,third_quarter,MED,Menococcal meningitis vaccine approval.,"HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2012-10-18T10:04:21.373000-04:00
1305279,3d4be442-0f10-43fd-bb1d-0c49a28d98ad,Q3,"O'NEILL, ATHY & CASEY, P.C.",42752,COALITION OF BOSTON TEACHING HOSPITALS,2012,third_quarter,MED,Funding for federally-sponsored medical research,"HOUSE OF REPRESENTATIVES,SENATE",110000,,0,0,2012-10-18T10:20:51.213000-04:00
1305384,85c46eee-2c65-4b24-8f1c-be09069fe1c2,Q3,FAEGRE DRINKER BIDDLE & REATH LLP,12631,AMERICAN SOCIETY OF TROPICAL MEDICINE AND HYGIENE,2012,third_quarter,MED,Public Health Programs for Infectious and Tropical Disease;  Department of Defense Tropical Medicine Research; National Institutes of Health Tropical Medicine Programs; S. Res. 429 - World Malaria Day Resolution.,"Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2012-10-18T10:36:30.757000-04:00
1305406,775aa327-9557-4fda-84c6-9e4e6ec44c20,Q3,"O'NEILL, ATHY & CASEY, P.C.",42752,MASS GENERAL BRIGHAM,2012,third_quarter,MED,Funding for federally-sponsored medical research,"HOUSE OF REPRESENTATIVES,SENATE",140000,,0,0,2012-10-18T10:43:38.607000-04:00